2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Establishment of InMotion, an independent, fee-free community center for persons with movement disorders

D.E. Riley, K.M. Jaffe, J.Z. Peters (Warrensville Heights, OH, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

European physiotherapy guideline for Parkinson’s disease: Information for neurologists

D.L.M. Radder, M.J. Faber, N.M. de Vries, B.R. Bloem, S.H.J. Keus (Nijmegen, Netherlands)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Evaluation of droxidopa dosing and clinical response in 50 consecutive patients with Parkinson’s disease and symptomatic neurogenic orthostatic hypotension

S.H. Isaacson, S. Brillman, N. Chhabria (Boca Raton, FL, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Evaluation of impulse control disorders in fluctuating Parkinson’s disease patients under opicapone treatment

N. Lopes, J. Ferreira, A. Lees, T. Müller, H. Reichmann, H. Gama, A. Santos, C. Oliveira, J.F. Rocha, P. Soares-da-Silva (Coronado, Portugal)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Evaluation of respiratory and depression levels of patients with Parkinson’s disease

E.E. Okuyucu, O. Canbay, E. Dogru, I. Huzmeli, N. Katayifci, F. Duman, N.C. Korkmaz, B. Yucekaya, E. Seker (Hatay, Turkey)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Examining the clinical profile of nelotanserin, a novel agent in development for Lewy body dementia

W. Wen, K. Kishnani, S. Ramaswamy, S. Piscitelli (New York, NY, USA)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Exercise-induced adaptive neuroplasticity in the MPTP mouse model of Parkinson’s disease

C.J.H.M. Klemann, G. Poelmans, G.J.M. Martens, J.E. Visser (Nijmegen, Netherlands)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Exome sequencing reveals homozygous mutations in SACS, ATCAY, and MCOLN1 in three Pakistani families with complex dystonia

H. Manzoor, N. Brüggemann, F. Hinrichs, H.M.J. Hussain, M. Wajid, T. Bäumer, A. Münchau, S. Naz, K. Lohmann (Lahore, Pakistan)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Experience of pallidal deep brain stimulation (DBS) in dystonia at a tertiary care centre in India

D. Srinivas, R. Yadav, K. Jhunjhunwala, P. Pal (Bangalore, India)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Experience with utilization of rytary in the clinical setting

Y. Kianirad, T. Simuni, C. Zadikoff, D. Bega, M. Afshari, S. Jonnalagadda (Chicago, IL, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2